EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,874,375 | -18.9% | 118,857 | 0.0% | 0.26% | -22.4% |
| Q2 2023 | $2,310,580 | +1.8% | 118,857 | +48.6% | 0.34% | +0.6% |
| Q1 2023 | $2,269,600 | -34.7% | 80,000 | -32.7% | 0.34% | -33.1% |
| Q4 2022 | $3,474,190 | +10.6% | 118,857 | 0.0% | 0.50% | +31.2% |
| Q3 2022 | $3,140,000 | +18.7% | 118,857 | +90.9% | 0.38% | -19.6% |
| Q3 2020 | $2,645,000 | -78.4% | 62,262 | -75.6% | 0.48% | -59.8% |
| Q2 2020 | $12,264,000 | +4.3% | 255,616 | 0.0% | 1.19% | -27.8% |
| Q1 2020 | $11,758,000 | – | 255,616 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |